マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
医療診断用AIの世界市場規模は2023年で13億ドル、2028年に37億ドル、市場の平均年成長率は23.2%増で推移する見通しです。
レポートは医療診断用AIの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(コンポーネント別市場、用途別市場、等)を中心に構成されています。また競合状況、主要企業情報(11社)、ケーススタディ、特許分析などの分析も加味し、医療診断用AI市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
市場規模(US$)
ソフトウェア
サービス
ハードウェア
・プロセッサ
-MPU
-GPU(画像処理装置)
-FPGA
-ASIC
・メモリ
・ネットワーク
-アダプタ
-スイッチ
-インターコネクト
※(市場規模US$)
専門分野別、In vivo診断
・放射線科
・心臓病学
・神経内科
・産婦人科
・眼科
・その他
モダリティ別、In vivo診断
・CT
・X線
・MRI
・超音波
・その他
IVD(体外診断)
※(市場規模US$)
・病院
・画像診断センター
・診断ラボラトリー
・その他エンドユーザー
※(市場規模US$)
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
・市場ダイナミクス(促進要因、障壁、機会、課題)
・バリューチェーン分析
・エコシステムマッピング
・ケーススタディ
・技術分析
・業界構造分析
・産業傾向
・貿易分析
・プライシング分析
・特許分析
・競合状況
・市場シェア分析
・MICROSOFT
・NVIDIA CORPORATION
・MERATIVE
・GOOGLE (ALPHABET, INC)
・INTEL CORPORATION
・SIEMENS HEALTHINEERS
・GE HEALTHCARE
・ADVANCED MICRO DEVICES, INC
・KONINKLIJKE PHILIPS NV
・DIGITAL DIAGNOSTICS, INC
・INFORMAI
その他企業
・HEARTFLOW, INC
・ENLITIC, INC
・AIDENCE
・BUTTERFLY NETWORK, INC
・NANO X IMAGING LTD
・VIZAI, INC
・QUIBIM
・QUREAI
・THERAPIXEL
・AIDOC
・LUNIT, INC
・ECHONOUS, INC
・ICOMETRIX
・BRAINOMIX
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED 46
1.3.2 YEARS CONSIDERED 46
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT
2.1 RESEARCH DATA
・ FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
・ FIGURE 2 PRIMARY SOURCES
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
・ FIGURE 5 MARKET SIZE ESTIMATION
・ TABLE 1 FACTOR ANALYSIS
・ FIGURE 6 AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
・ FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
・ FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS 60
2.5 LIMITATIONS 60
2.5.1 SCOPE-RELATED LIMITATIONS
2.5.2 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
・ TABLE 2 RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET
2.7 AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS
・ FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET
4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
・ FIGURE 14 RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF BIG DATA TO DRIVE MARKET
4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2022)
・ FIGURE 15 IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA IN 2022
4.3 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 16 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE
4.4 AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX
・ FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 AI IN MEDICAL DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
・ FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5.1 INTRODUCTION
・ FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 INFLUX OF BIG DATA
5.1.1.2 GROWING CROSS-INDUSTRY PARTNERSHIPS & COLLABORATIONS
5.1.1.3 INCREASING DEMAND FOR AI-BASED SOLUTIONS TO REDUCE WORK PRESSURE ON RADIOLOGISTS
5.1.1.4 RISING GOVERNMENT INITIATIVES TO SUPPORT AI-BASED TECHNOLOGIES 70
5.1.1.5 AVAILABILITY OF FUNDING FOR AI-BASED STARTUPS
5.1.2 RESTRAINTS
5.1.2.1 INADEQUATE AI WORKFORCE AND AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
5.1.3 OPPORTUNITIES
5.1.3.1 UNTAPPED EMERGING MARKETS
5.1.3.2 INCREASING FOCUS ON DEVELOPING HUMAN-AWARE AI SYSTEMS
5.1.4 CHALLENGES
5.1.4.1 RELUCTANCE TO ADOPT AI-BASED TECHNOLOGIES
5.1.4.2 BUDGETARY CONSTRAINTS
5.1.4.3 UNSTRUCTURED HEALTHCARE DATA
5.1.4.4 DATA PRIVACY CONCERNS
5.1.4.5 LIMITED INTEROPERABILITY
5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
・ FIGURE 20 REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS
5.3 VALUE CHAIN ANALYSIS
・ FIGURE 21 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN
5.3.1 UPSTREAM
5.3.2 MID-STREAM
5.3.3 DOWNSTREAM
5.4 ECOSYSTEM MAPPING
・ FIGURE 22 AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM
5.4.1 ROLE IN ECOSYSTEM 78
5.5 CASE STUDIES
5.5.1 MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM
5.5.2 RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES
5.5.3 NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING
5.5.4 ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND
5.5.5 WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS
5.6 TECHNOLOGY ANALYSIS
5.6.1 MACHINE LEARNING 81
5.6.2 NATURAL LANGUAGE PROCESSING
5.6.3 COMPUTER VISION 81
・ TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.7 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4 AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 INDUSTRY TRENDS
5.8.1 ARTIFICIAL INTELLIGENCE IN HEALTHCARE
5.8.1.1 KEY TO AI IN HEALTHCARE: DATA
5.8.1.2 AR AND MR IN HEALTHCARE SETTINGS
5.8.1.3 HEALTHCARE PRIVACY AND SECURITY IN 2022
5.8.1.4 GROWING DEMAND FOR AI AMONG COMPANIES OFFERING AT-HOME IVD TESTING SERVICES
5.9 TRADE ANALYSIS
・ FIGURE 23 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
・ FIGURE 24 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
5.10 TARIFF AND REGULATORY ANALYSIS
5.10.1 TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE
・ TABLE 5 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022
・ TABLE 6 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022
・ TABLE 7 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.3 NORTH AMERICA
・ FIGURE 25 ALGORITHMS CLEARED BY US FDA, 2008 TO 2023
5.10.3.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.10.3.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.10.3.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
5.10.3.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.10.3.5 FUTURE OF LIFE INSTITUTE’S ASILOMAR AI PRINCIPLES
5.10.4 EUROPE
5.10.4.1 EUROPEAN MEDICAL DEVICES REGULATION (EU) 2017/745 AND IN-VITRO DIAGNOSTIC MEDICAL DEVICES REGULATION (EU) 2017/746, IN COMBINATION WITH GENERAL DATA PROTECTION REGULATION 2016/679
5.10.4.2 AI ACT (ARTIFICIAL INTELLIGENCE ACT)
5.10.5 ASIA PACIFIC
5.10.5.1 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
5.10.6 REST OF THE WORLD 93
5.10.6.1 PROTECTION OF PERSONAL INFORMATION ACT
5.11 PRICING ANALYSIS
・ FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR)
・ TABLE 12 AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE
5.11.1 AVERAGE SELLING PRICE TREND
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS
・ FIGURE 27 PATENT PUBLICATION TRENDS (2019-2023)
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
・ FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023)
・ TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET
5.13 KEY CONFERENCES AND EVENTS (2023–2024)
・ TABLE 14 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS
・ FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
・ TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
5.14.2 BUYING CRITERIA 100
・ FIGURE 30 KEY BUYING CRITERIA FOR END USERS
・ TABLE 17 KEY BUYING CRITERIA FOR END USERS
5.15 UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET
・ TABLE 18 AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS
5.16 END-USER EXPECTATIONS
・ TABLE 19 AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS
5.17 REIMBURSEMENT SCENARIO
・ TABLE 20 SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE
・ TABLE 21 DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT
5.17.1 REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY
6.1 INTRODUCTION
・ TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
6.2 SOFTWARE
6.2.1 USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS
・ TABLE 24 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 25 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.3 SERVICES
6.3.1 RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH
・ TABLE 26 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 27 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4 HARDWARE
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
・ TABLE 28 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 29 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 30 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 31 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2 PROCESSORS
・ TABLE 32 PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 33 PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 34 PROCESSORS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 35 PROCESSORS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.1 MPU
6.4.2.1.1 MPUS TO HOLD LARGEST SHARE OF PROCESSORS MARKET
・ TABLE 36 MPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 37 MPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.2 GPU
6.4.2.2.1 GPUS PLAY CRUCIAL ROLE IN ENHANCING ACCURACY AND EFFICACY OF IMAGING
・ TABLE 38 GPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 39 GPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.3 FPGA
6.4.2.3.1 WIDE USAGE POTENTIAL TO DRIVE DEMAND
・ TABLE 40 FPGA MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 41 FPGA MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.4 ASIC
6.4.2.4.1 RAPID OPERATIONS TO SUPPORT END-USER DEMAND
・ TABLE 42 ASIC MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 43 ASIC MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.3 MEMORY
6.4.3.1 DEVELOPMENT OF HIGH-BANDWIDTH MEMORY FOR AI APPLICATIONS TO DRIVE MARKET
・ TABLE 44 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 45 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.4 NETWORKS
・ TABLE 46 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 47 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 48 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 49 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.4.1 ADAPTERS
6.4.4.1.1 ADAPTERS TO HOLD LARGEST SHARE OF NETWORKS MARKET
・ TABLE 50 ADAPTERS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 51 ADAPTERS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.4.2 SWITCHES
・ TABLE 52 SWITCHES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 53 SWITCHES MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.4.3 INTERCONNECTS
6.4.4.3.1 NEED FOR EFFICIENT DATA TRANSMISSION TO DRIVE MARKET
・ TABLE 54 INTERCONNECTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 55 INTERCONNECTS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
7.1 INTRODUCTION
・ TABLE 56 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 57 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
7.2 IN VIVO DIAGNOSTICS
7.2.1 IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY
・ TABLE 58 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 59 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 60 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 61 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.1 RADIOLOGY
7.2.1.1.1 AI-BASED DIAGNOSTIC TOOLS TO REDUCE WORK PRESSURE ON RADIOLOGISTS 133
・ TABLE 62 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 63 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.2 CARDIOLOGY
7.2.1.2.1 RISING COMPLEXITIES ASSOCIATED WITH CVD TO DRIVE MARKET
・ TABLE 64 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 65 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.3 NEUROLOGY
7.2.1.3.1 INCREASING PREVALENCE OF CRITICAL BRAIN DISORDERS TO DRIVE MARKET 136
・ TABLE 66 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 67 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.4 OBSTETRICS/GYNECOLOGY
7.2.1.4.1 RISING USE OF MINIMALLY INVASIVE TECHNIQUES IN GYNECOLOGY PROCEDURES TO DRIVE MARKET
・ TABLE 68 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 69 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.5 OPHTHALMOLOGY
7.2.1.5.1 RISING NEED FOR EARLY DETECTION & PREVENTION OF EYE DISEASES TO DRIVE MARKET
・ TABLE 70 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 71 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.6 OTHER SPECIALTIES
・ TABLE 72 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 73 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2 IN VIVO DIAGNOSTICS MARKET, BY MODALITY
・ TABLE 74 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 75 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 76 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 77 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.1 CT
7.2.2.1.1 RISING AVAILABILITY OF CARDIAC CT DEVICES WITH AI SOLUTIONS TO DRIVE MARKET
・ TABLE 78 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 79 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.2 X-RAY
7.2.2.2.1 INNOVATIVE AI SOLUTIONS FOR X-RAY IMAGING BY KEY PLAYERS TO DRIVE MARKET
・ TABLE 80 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 81 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.3 MRI
7.2.2.3.1 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF AI IN MRI
・ TABLE 82 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 83 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.4 ULTRASOUND
7.2.2.4.1 INCREASING PREVALENCE OF OVARIAN CANCER TO BOOST DEMAND
・ TABLE 84 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 85 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.5 OTHER MODALITIES
・ TABLE 86 FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING
・ TABLE 87 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 88 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2022–2028 (USD MILLION)
7.3 IN VITRO DIAGNOSTICS
7.3.1 INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
・ TABLE 89 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 90 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2028 (USD MILLION)
8.1 INTRODUCTION
・ TABLE 91 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 92 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
8.2 HOSPITALS 156
8.2.1 INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET
・ TABLE 93 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 94 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2028 (USD MILLION)
8.3 DIAGNOSTIC IMAGING CENTERS
8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
・ TABLE 95 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 96 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2022–2028 (USD MILLION)
8.4 DIAGNOSTIC LABORATORIES
8.4.1 RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET
・ TABLE 97 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 98 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2028 (USD MILLION)
8.5 OTHER END USERS
・ TABLE 99 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 100 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2028 (USD MILLION)
9.1 INTRODUCTION
・ TABLE 101 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017–2021 (USD MILLION)
・ TABLE 102 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
・ FIGURE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 103 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 104 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
・ TABLE 105 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 106 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 107 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 108 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 109 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 110 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 111 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 112 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 113 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 114 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 115 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 116 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 117 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 118 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 119 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 120 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.2.2 US
9.2.2.1 INCREASING VOLUME OF IMAGING PROCEDURES TO DRIVE MARKET
・ TABLE 121 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 122 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 123 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 124 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 125 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 126 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 127 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 128 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 129 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 130 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 131 US: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 132 US: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 133 US: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 134 US: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 135 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 136 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 RESEARCH GRANTS AND IMPROVED ACADEMICS IN RADIOLOGY TO DRIVE MARKET
・ TABLE 137 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 138 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 139 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 140 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 141 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 142 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 143 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 144 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 145 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 146 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 147 CANADA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 148 CANADA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 149 CANADA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 150 CANADA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 151 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 152 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
・ TABLE 153 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 154 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
・ TABLE 155 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 156 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 157 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 158 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 159 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 160 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 161 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 162 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 163 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 164 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 165 EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 166 EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 167 EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 168 EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 169 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 170 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 RISING GOVERNMENT SUPPORT TO DRIVE ADOPTION OF AI IN MEDICAL DIAGNOSTICS
・ TABLE 171 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 172 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 173 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 174 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 175 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 176 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 177 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 178 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 179 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 180 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 181 GERMANY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 182 GERMANY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 183 GERMANY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 184 GERMANY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 185 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 186 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 AVAILABILITY OF FUNDING FOR COMPANIES TO ENHANCE AI RESEARCH IN MEDICAL IMAGING
・ TABLE 187 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 188 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 189 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 190 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 191 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 192 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 193 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 194 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 195 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 196 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 197 FRANCE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 198 FRANCE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 199 FRANCE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 200 FRANCE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 201 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 202 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 INCREASING RADIOGRAPHY PROCEDURES TO DRIVE MARKET
・ TABLE 203 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 204 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 205 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 206 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 207 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 208 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 209 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 210 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 211 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 212 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 213 UK: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 214 UK: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 215 UK: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 216 UK: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 217 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 218 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 INCREASING VOLUME OF EHRS AND EMRS DUE TO RISING GERIATRIC POPULATION TO DRIVE DEMAND FOR AI SOLUTIONS
・ TABLE 219 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 220 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 221 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 222 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 223 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 224 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 225 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 226 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 227 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 228 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 229 ITALY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 230 ITALY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 231 ITALY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 232 ITALY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 233 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 234 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 GROWING AWARENESS OF AI IN SPAIN TO FAVOR MARKET GROWTH
・ TABLE 235 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 236 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 237 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 238 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 239 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 240 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 241 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 242 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 243 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 244 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 245 SPAIN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 246 SPAIN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 247 SPAIN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 248 SPAIN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 249 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 250 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.7 REST OF EUROPE
・ TABLE 251 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 252 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 253 REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 254 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 255 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 256 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 257 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 258 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 259 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 260 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 261 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 262 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 263 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 264 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 265 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 266 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
・ FIGURE 32 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 267 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・ TABLE 268 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
・ TABLE 269 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 270 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 271 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 272 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 273 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 274 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 275 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 276 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 277 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 278 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 279 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 280 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 281 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 282 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 283 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 284 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 RISING USE OF AI IN CLINICAL DECISION-MAKING TO DRIVE MARKET
・ TABLE 285 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 286 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 287 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 288 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 289 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 290 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 291 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 292 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 293 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 294 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 295 CHINA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 296 CHINA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 297 CHINA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 298 CHINA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 299 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 300 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 STRONG HEALTHCARE INFRASTRUCTURE TO DRIVE UPTAKE OF ADVANCED AI SOLUTIONS
・ TABLE 301 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 302 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 303 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 304 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 305 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 306 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 307 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 308 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 309 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 310 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 311 JAPAN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 312 JAPAN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 313 JAPAN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 314 JAPAN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 315 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 316 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 FAVORABLE GOVERNMENT INITIATIVES FOR R&D INVESTMENTS TO DRIVE MARKET
・ TABLE 317 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 318 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 319 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 320 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 321 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 322 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 323 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 324 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 325 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 326 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 327 INDIA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 328 INDIA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 329 INDIA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 330 INDIA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 331 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 332 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
・ TABLE 333 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 334 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 335 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 336 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 337 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 338 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 339 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 340 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 341 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 342 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 343 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 344 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 345 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 346 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 347 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 348 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS
9.5.2 LATIN AMERICA: RECESSION IMPACT
・ TABLE 349 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 350 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 351 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 352 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 353 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 354 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 355 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 356 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 357 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021(USD MILLION)
・ TABLE 358 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 359 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 360 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 361 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 362 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 363 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 364 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
・ TABLE 365 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・ TABLE 366 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・ TABLE 367 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・ TABLE 368 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・ TABLE 369 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・ TABLE 370 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・ TABLE 371 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・ TABLE 372 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・ TABLE 373 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 374 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 375 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 376 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 377 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・ TABLE 378 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・ TABLE 379 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・ TABLE 380 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
・ TABLE 381 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
10.3 REVENUE ANALYSIS
・ FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2017–2022
10.4 MARKET SHARE ANALYSIS
・ FIGURE 34 AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022)
・ TABLE 382 AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
・ FIGURE 35 AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022)
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS 275
10.5.3 PERVASIVE PLAYERS 275
10.5.4 PARTICIPANTS
・ FIGURE 36 AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022
10.5.5 COMPANY FOOTPRINT ANALYSIS
・ TABLE 383 OVERALL COMPANY FOOTPRINT (TEN PLAYERS)
・ TABLE 384 APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS)
・ TABLE 385 REGIONAL FOOTPRINT (TEN PLAYERS)
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES 278
10.6.3 RESPONSIVE COMPANIES
10.6.4 STARTING BLOCKS 278
・ FIGURE 37 AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022)
10.6.5 COMPETITIVE BENCHMARKING
・ TABLE 386 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
・ TABLE 387 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS
・ TABLE 388 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020–SEPTEMBER 2023
10.7.2 DEALS
・ TABLE 389 KEY DEALS, JANUARY 2020–SEPTEMBER 2023
10.7.3 OTHER DEVELOPMENTS
・ TABLE 390 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–SEPTEMBER 2023)
11.1 KEY PLAYERS 284
(BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS)*
11.1.1 MICROSOFT
・ TABLE 391 MICROSOFT: COMPANY OVERVIEW 284
・ FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022)
11.1.2 NVIDIA CORPORATION
・ TABLE 392 NVIDIA CORPORATION: COMPANY OVERVIEW
・ FIGURE 39 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022)
11.1.3 MERATIVE
・ TABLE 393 MERATIVE: COMPANY OVERVIEW 294
・ FIGURE 40 IBM: COMPANY SNAPSHOT (2021) 295
11.1.4 GOOGLE (ALPHABET, INC.)
・ TABLE 394 GOOGLE: COMPANY OVERVIEW
・ FIGURE 41 GOOGLE: COMPANY SNAPSHOT (2022)
11.1.5 INTEL CORPORATION 302
・ TABLE 395 INTEL CORPORATION: COMPANY OVERVIEW
・ FIGURE 42 INTEL CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6 SIEMENS HEALTHINEERS
・ TABLE 396 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
・ FIGURE 43 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
11.1.7 GE HEALTHCARE
・ TABLE 397 GE HEALTHCARE: COMPANY OVERVIEW
・ FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
11.1.8 ADVANCED MICRO DEVICES, INC.
・ TABLE 398 ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW
・ FIGURE 45 XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022)
11.1.9 KONINKLIJKE PHILIPS N.V.
・ TABLE 399 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
・ FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.10 DIGITAL DIAGNOSTICS, INC.
・ TABLE 400 DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW
11.1.11 INFORMAI
・ TABLE 401 INFORMAI: COMPANY OVERVIEW 326
11.2 OTHER PLAYERS
11.2.1 HEARTFLOW, INC. 328
11.2.2 ENLITIC, INC.
11.2.3 AIDENCE
11.2.4 BUTTERFLY NETWORK, INC.
11.2.5 NANO X IMAGING LTD.
11.2.6 VIZ.AI, INC.
11.2.7 QUIBIM
11.2.8 QURE.AI
11.2.9 THERAPIXEL
11.2.10 AIDOC
11.2.11 LUNIT, INC.
11.2.12 ECHONOUS, INC.
11.2.13 ICOMETRIX
11.2.14 BRAINOMIX
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.